Neomed Management appeared to be the VC, which was created in 1997. The fund was located in Europe if to be more exact in Norway. The main department of described VC is located in the Oslo.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Neomed Management, startups are often financed by Andera Partners, Gimv, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Gimv, Legend Capital, BioMedPartners. In the next rounds fund is usually obtained by Andera Partners, OrbiMed, Gimv.
The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sonendo, Creabilis, Wilson Therapeutics.
The overall number of key employees were 3.
The typical startup value when the investment from Neomed Management is 10-50 millions dollars. The top activity for fund was in 2014. The top amount of exits for fund were in 2016. The fund is constantly included in 2-6 investment rounds annually. This Neomed Management works on 7 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Funds with similar focus
|$37M||01 Mar 2021||Oxford, Oxfordshire, United Kingdom|
|$50M||05 Feb 2020||Bavaria|
|$85M||06 Jan 2020||California, United States|
|$10M||16 Oct 2018||Zurich, Zurich, Switzerland|
|$50M||18 Sep 2017||California, United States|
|$12M||21 Jun 2017||Lebanon, New Hampshire, United States|
Axonics Modulation Technologies
|$14M||02 May 2017||Irvine, California, United States|
|$35M||13 Dec 2016||California, United States|
|$29M||09 Mar 2016||Galway|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.